Advanced search×

Embolic protection devices: no room for standardization.

C C Setacci

Eur J Vasc Endovasc Surg 39(6):667 (2010) PMID 20381386

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ejvs.2010.03.016
Version: za2963e q8zab q8zb3 q8zc2 q8zde q8ze8 q8zfd q8zg3

Similar articles you may find interesting…

  1. Evaluating the Effects of NAMI's Consumer Presentation Program, In Our Own Voice.
    Madeline Brennan and John H McGrew

    Psychiatr Rehabil J (2013) PMID 23647146

    The majority of viewers responded very positively. Qualitative responses suggested that the program is meeting NAMI's goals for audience members: educating the public and offering a hope-inspiring message of recovery. The program's effects generalized across consumers and nonconsumers with few diffe...
  2. The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice.
    Donna R Parker, Charles B Eaton, and Joseph Wroblewski

    BMC Fam Pract 14(1):56 (2013) PMID 23641803

    We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. DISCUSSION: Using a multi-modal intervention of patient activation and a technology-s...
    PDF not found
  3. Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy.
    Ahmed M Maklad, Elsayed M Ali, and Emad Eldin Nabil

    Int Arch Med 6(1):21 (2013) PMID 23641800

    In Sohag study the age of patients ranged from 35--72ys with Median 56 years, 24 patients were male (80%) and 6 patients were female (20%). In Assiut study the mean of age was 57.30 years, median 58.5 years with peak incidence in 7th decade (9 cases) then in 6th decade 7 cases (23.33%). Performance...
    PDF not found